| CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment N Mattsson, H Zetterberg, O Hansson, N Andreasen, L Parnetti, ... Jama 302 (4), 385-393, 2009 | 1465 | 2009 |
| ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial Y Freund-Levi, M Eriksdotter-Jönhagen, T Cederholm, H Basun, ... Archives of neurology 63 (10), 1402-1408, 2006 | 1033 | 2006 |
| Mild cognitive impairment and deficits in instrumental activities of daily living: a systematic review K Jekel, M Damian, C Wattmo, L Hausner, R Bullock, PJ Connelly, ... Alzheimer's research & therapy 7, 1-20, 2015 | 681 | 2015 |
| Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer’s disease M Eriksdotter Jönhagen, A Nordberg, K Amberla, L Bäckman, T Ebendal, ... Dementia and geriatric cognitive disorders 9 (5), 246-257, 1998 | 562 | 1998 |
| Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype L Vermunt, SAM Sikkes, A Van Den Hout, R Handels, I Bos, ... Alzheimer's & Dementia 15 (7), 888-898, 2019 | 527 | 2019 |
| Effects of docosahexaenoic acid–rich n− 3 fatty acid supplementation on cytokine release from blood mononuclear leukocytes: the OmegAD study I Vedin, T Cederholm, YF Levi, H Basun, A Garlind, GF Irving, ... The American journal of clinical nutrition 87 (6), 1616-1622, 2008 | 376 | 2008 |
| Resolution of inflammation is altered in Alzheimer's disease X Wang, M Zhu, E Hjorth, V Cortés-Toro, H Eyjolfsdottir, C Graff, ... Alzheimer's & Dementia 11 (1), 40-50. e2, 2015 | 345 | 2015 |
| Multimorbidity and functional impairment–bidirectional interplay, synergistic effects and common pathways A Calderón‐Larrañaga, DL Vetrano, L Ferrucci, SW Mercer, A Marengoni, ... Journal of internal medicine 285 (3), 255-271, 2019 | 334 | 2019 |
| CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival T Skillbäck, B Farahmand, JW Bartlett, C Rosén, N Mattsson, K Nägga, ... Neurology 83 (21), 1945-1953, 2014 | 305 | 2014 |
| Determinants of costs of care for patients with Alzheimer's disease L Jönsson, ME Jönhagen, L Kilander, H Soininen, M Hallikainen, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2006 | 300 | 2006 |
| Omega-3 fatty acids enhance phagocytosis of alzheimer's disease-related amyloid-β 42 by human microglia and decrease inflammatory markers E Hjorth, M Zhu, VC Toro, I Vedin, J Palmblad, T Cederholm, ... Journal of Alzheimer's Disease 35 (4), 697-713, 2013 | 279 | 2013 |
| Clinical validation of 18F-AZD4694, an amyloid-β–specific PET radioligand Z Cselényi, ME Jönhagen, A Forsberg, C Halldin, P Julin, M Schou, ... Journal of Nuclear Medicine 53 (3), 415-424, 2012 | 259 | 2012 |
| Postoperative delirium in elderly patients after major abdominal surgery K Olin, M Eriksdotter-Jönhagen, A Jansson, MK Herrington, ... Journal of British Surgery 92 (12), 1559-1564, 2005 | 244 | 2005 |
| Omega‐3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms Y Freund‐Levi, H Basun, T Cederholm, G Faxén‐Irving, A Garlind, M Grut, ... International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2008 | 237 | 2008 |
| Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia T Skillbäck, BY Farahmand, C Rosen, N Mattsson, K Nägga, L Kilander, ... Brain 138 (9), 2716-2731, 2015 | 216 | 2015 |
| The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease P Nordström, D Religa, A Wimo, B Winblad, M Eriksdotter European heart journal 34 (33), 2585-2591, 2013 | 203 | 2013 |
| Age and diagnostic performance of Alzheimer disease CSF biomarkers N Mattsson, E Rosen, O Hansson, N Andreasen, L Parnetti, M Jonsson, ... Neurology 78 (7), 468-476, 2012 | 201 | 2012 |
| Mortality risk after dementia diagnosis by dementia type and underlying factors: a cohort of 15,209 patients based on the Swedish Dementia Registry S Garcia-Ptacek, B Farahmand, I Kåreholt, D Religa, ML Cuadrado, ... Journal of Alzheimer's Disease 41 (2), 467-477, 2014 | 200 | 2014 |
| Age, frailty, and comorbidity as prognostic factors for short-term outcomes in patients with coronavirus disease 2019 in geriatric care S Hägg, J Jylhävä, Y Wang, H Xu, C Metzner, M Annetorp, ... Journal of the American Medical Directors Association 21 (11), 1555-1559. e2, 2020 | 198 | 2020 |
| Patient-and proxy-reported utility in Alzheimer disease using the EuroQoL L Jönsson, N Andreasen, L Kilander, H Soininen, G Waldemar, ... Alzheimer Disease & Associated Disorders 20 (1), 49-55, 2006 | 195 | 2006 |
Sara Garcia-PtacekMD, PhD Karolinska University HospitalVerified email at ki.se
